Rockwell Medical (RMTI) EBT Margin Growth (3y) (2013 - 2026)
Rockwell Medical (RMTI) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 1,282.00 |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 58.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -861.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -1,020.00 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | -995.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1,157.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Rockwell Medical | 29.81 Mn | 5.01 Mn | 3.24 Mn | 1,096.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,680.00 |
| Mar 31, 2026 | -3,251.00 |
| Dec 31, 2025 | 82.00 |
| Sep 30, 2025 | 935.00 |
| Jun 30, 2025 | 1,043.00 |
| Mar 31, 2025 | 3,468.00 |
| Dec 31, 2024 | 5,334.00 |
| Sep 30, 2024 | 5,277.00 |
| Jun 30, 2024 | 5,587.00 |
| Mar 31, 2024 | 4,244.00 |
| Dec 31, 2023 | 5,235.00 |
| Sep 30, 2023 | 3,912.00 |
| Jun 30, 2023 | 1,936.00 |
| Mar 31, 2023 | 4,344.00 |
| Dec 31, 2022 | 3,746.00 |
| Sep 30, 2022 | 3,171.00 |
| Jun 30, 2022 | 4,623.00 |
| Mar 31, 2022 | 1,479.00 |
| Dec 31, 2021 | 107.00 |
| Sep 30, 2021 | -1,542.00 |